
News desk
Market news
Latest news about unlisted stock investment, from the original publishers.
Archive · 1,400 items
More coverage


Vardan Ceqube India Investments Invests in NeRL
Read original
PharmEasy in talks to raise upto $300 million, valuation may drop by half
Read original-
Motilal Oswal Financial Services announces buyback of shares at Rs 1,100 apiece

-
PharmEasy pulls out market listing plan

-
Stockify taps rising demand for pre-IPO shares among global investors

-
Should investors blindly follow the trend and invest in unlisted shares?

-
PharmEasy Floats Rights Issue to Raise ₹750 crore

-
Lupin completes acquisition of portfolio of brands from Anglo-French Drugs & Industries

-
New cargo terminal at Cial to be inaugurated by September

-
HDFC Securities Unveils Next-Gen InvestRight App with Advanced Features

-
Motilal Oswal turns bullish on Transport Corp stock, sees 26% upside

-
PharmEasy’s annus horribilis may get worse before it gets better

-
Confused About Investing In Unlisted Shares?

-
India IPO pipeline to continue in 2023 despite global uncertainty

-
Should you invest in unlisted equities during a bull run

-
Piyush Goyal: Had an engaging interaction with leading business leaders in UAE

-
PharmEasy’s Parent Raises Debt Funding

-
Motilal Oswal arm announced to invests Rs 400 crore in Pan Heathcare

-
How Pharmeasy Founders Changed the Face of Pharmacy

-
Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to board

-
HDFC Bank greenlights HDB Financial Services IPO, explores additional stake sale

-
Motilal Oswal Home Finance Posts Steady Growth In Q3 FY24

-
PharmEasy’s parent API Holdings postpones IPO citing market conditions

